Clinical Trial Update: Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining brain uptake and safety of an imaging agent in Alzheimer's disease, amnestic mild cognitive impairment, and healthy volu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: GE Healthcare | Conditions: Alzheimer's Disease, Amnestic Mild Cognitive Impairment | Phase 2 | Status: COMPLETED